To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

9.4% THC improves neuropathic pain and quality of life compared to placebo over 5 days

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2018

9.4% THC improves neuropathic pain and quality of life compared to placebo over 5 days

Vol: 7| Issue: 10| Number:7| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:1
Journal Level of Evidence:N/A

Smoked cannabis for chronic neuropathic pain: A randomized controlled trial

Send to CMAJ. 2010 Oct 5;182(14):E694-701. doi: 10.1503/cmaj.091414

Contributing Authors:
T Wang A Robinson MA Ware S Shapiro T Ducruet T Huynh A Gamsa GJ Bennett JP Collet

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

21 patients with neuropathic pain received placebo, 2.5%, 6.0%, and 9.4% THC in a randomized order. The primary outcome was average pain intensity over time, and patients were also assessed for sleep, mood, quality of life, and subjective feelings of happiness, relaxation, stress, and feeling high. Adverse effects were also documented. Results indicate that only the 9.4% THC dose significantly imp...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue